Wexford Capital LP Exagen Inc. Transaction History
Wexford Capital LP
- $310 Million
- Q2 2025
A detailed history of Wexford Capital LP transactions in Exagen Inc. stock. As of the latest transaction made, Wexford Capital LP holds 416,348 shares of XGN stock, worth $4.84 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
416,348Holding current value
$4.84 Million% of portfolio
0.94%Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
54Shares Held
8.86MCall Options Held
0Put Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$19.7 Million0.18% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6851KShares$9.9 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL719KShares$8.36 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA682KShares$7.93 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$6.18 Million0.03% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $189M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...